Inhibrx Biosciences, Inc. INBX 深 沪
已收盘 07-02 16:00:00 美东时间
97.58
+2.640
+2.78%
华盛通- 最 高97.59
- 今 开96.40
- 成交量 21.51万股
- 最 低 91.37
- 昨 收 94.94
- 总市值 14.32亿
- 52周最高 155.29
- 市盈率 静 --
- 换手率 1.47%
- 52周最低 20.55
- 委 比 -25.00%
- 总股本 1467.12万
- 历史最高 155.29
- 量 比 0.59
- 振 幅 6.55%
- 历史最低 7.67
- 每 手 1
- 风险率 30.98%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Inhibrx BLA for ozekibart accepted by FDA
The US FDA has accepted for review Inhibrx Biosciences' (INBX) BLA for ozekibart to treat unresectable or metastatic conventional chondrosarcoma. The application has an action date of April 14, 2027. ...
06-15 22:34
Inhibrx Biosciences Says FDA Accepts BLA Seeking Approval Of Ozekibart In Patients With Conventional Chondrosarcoma; PDUFA Goal Date Set For April 14, 2027
No filing review issues identified by FDA with PDUFA goal date set for April 14, 2027 If Approved, Ozekibart Would Be the First and Only FDA-Approved Treatment for Unresectable or Metastatic Conventional Chondrosarcoma SAN DIEGO, June 15, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) ...
06-15 21:19
科望医药 Elpiscience-B，递交IPO招股书，拟赴香港上市，中信证券独家保荐
2026年5月27日，来自江苏苏州的科望医药集团Elpiscience Biopharmaceuticals, Inc.(简称科望医药)在港交所递交...
06-07 21:27
核心产品为海外授权引进 市研率显著高于行业水平 科望医药第四次闯关港交所前景难料
记者 李思源 来源：经济参考报 成立近九年的临床阶段生物医药公司科望医药集团（简称“科望医药”）正朝着港股“18A”上市发起第四次冲刺。近日，科望医药向...
06-02 03:40
OX40激动剂联合K药头颈癌疗效翻倍，沉寂15年的OX40靶点终迎破局！
（来源：ACROBiosystems官方） 2026年5月，Inhibrx Biosciences（纳斯达克代码：INBX）公布了备受瞩目的HexAgon研究...
05-20 18:10
Inhibrx Biosciences GAAP EPS of -$2.15
Inhibrx Biosciences press release (INBX): Q1 GAAP EPS of -$2.15. Cash and Cash Equivalents. As of March 31, 2026, the Company had cash and cash equivalents of $161.7 million, as compared to $124.2 mil...
05-15 04:46
Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate
Inhibrx Biosciences (NASDAQ:INBX) reported quarterly losses of $(2.15) per share which missed the analyst consensus estimate of $(1.79) by 20.11 percent. This is a 23.21 percent increase over losses of $(2.80) per share
05-15 04:38
美股夜盘 | Fundrise Innovation Fund, LLC涨16.13%，奇景光电涨11.30%
Fundrise Innovation Fund, LLC涨16.13%；奇景光电涨11.30%；Inhibrx Biosciences, Inc.涨11.28%
05-11 13:01
美股夜盘 | Inhibrx Biosciences, Inc.涨10.90%，最新股价149.0美元
Inhibrx Biosciences, Inc.涨10.90%，报149.0美元
05-11 11:02
